Comorbidity risk-adjustment strategies are comparable among persons with hip fracture

David C Radley1, Daniel J Gottlieb, Elliot S Fisher

  • 1The Dartmouth Institute for Health Policy and Clinical Practice, Lebanon, NH 03756, USA.

Insights

Varying data sources and time frames had minimal impact on the predictive performance of risk adjustment models for hip fracture patients. The Clinical Classification Software (CCS) demonstrated the best overall predictive ability for mortality.

Area of Science:

  • Health Services Research
  • Medical Informatics
  • Geriatric Medicine

Background:

  • Accurate risk adjustment is crucial for evaluating healthcare quality and resource allocation in patient populations.
  • Claims-based risk adjustment models are widely used but their performance can be influenced by data source and identification time frames.
  • Hip fracture patients represent a vulnerable population where precise risk stratification is essential.

Purpose of the Study:

  • To assess the impact of different data sources (MedPar and Part B claims) and time frames (index hospitalization and 1-year preperiod) on the performance of risk adjustment instruments.
  • To compare the predictive accuracy of three common risk adjustment instruments in individuals with hip fracture.
  • To determine the magnitude of performance decline when altering data sources and time frames for comorbidity identification.

Main Methods:

  • Utilized Medicare claims data to identify incident hip fracture cases in 1999.
  • Evaluated three risk adjustment instruments: Iezzoni, Charlson Index (Romano adaptation), and Clinical Classification Software (CCS).
  • Assessed various implementation strategies by altering data source and time frame for comorbidity identification, predicting 1-year mortality using logistic regression.

Main Results:

  • All three instruments showed modest ability in predicting 1-year mortality post-hip fracture.
  • The Clinical Classification Software (CCS) exhibited the highest predictive performance (c=0.76), followed by Iezzoni (c=0.73) and Charlson (c=0.72).
  • Varying data sources and time frames had negligible effects on the models' predictive performance, with optimal results using both inpatient/outpatient claims and a preperiod for comorbidities.

Conclusions:

  • The comparable predictive capabilities of the evaluated risk adjustment instruments suggest that implementation ease should guide selection for hip fracture populations.
  • The choice of data source and time frame for comorbidity identification has a minimal impact on the predictive accuracy of these models in hip fracture patients.
  • Focusing on the simplicity of implementation may be more critical than data source or time frame variations when selecting risk adjustment tools for this demographic.
Abstract